A Letter From the President

Welcome to the Hunt BioVentures website, where you will find information regarding every aspect of our organization—what we do and where we operate; our mission, core values and leadership; as well as the latest company news. You can also read about Hunt's other operations throughout the world and our commitment to both the environment and the communities in which we operate.

Hunt BioVentures makes investments in young private and public companies with a focus on pharmaceuticals, medical devices and agricultural biotech opportunities. Since 2001, we have continually pursued companies with clinical efficacy data or strong human proxy data, which has typically meant companies with products in various stages of clinical trials. Although this later-stage approach will always be core to our investment strategy, we will occasionally pursue preclinical opportunities, especially those with exceptional management teams. Another important component of our strategy is to invest alongside other experienced life science investors in either a co-lead or follower manner.

In addition to the underlying intellectual property and market focus, Hunt BioVentures concentrates heavily on each member of the management team, as we believe people are the most critical component of any company. Finally, although we operate much like a fund, we do not manage third-party capital but instead invest capital generated by other Hunt affiliates. Hunt BioVentures invests $2 million to $5 million per round of a company's evolution with no ceiling on the total capital invested in any one company.

Mike Bierman
Managing Director
Hunt BioVentures

About Mike Bierman